Background In adults with advanced-stage Hodgkin's lymphoma, the CD30-directed
antibody–drug conjugate brentuximab vedotin combined with multiagent chemotherapy has …

Hodgkin lymphoma, a hematological malignancy of lymphoid origin that typically arises from
germinal-center B cells, has an excellent overall prognosis. However, the treatment of …

Approximately 1 in 640 adults between 20 and 40 years of age is a survivor of childhood
cancer. However, survival has often come at the expense of increased risk of long-term …

Hodgkin lymphoma (HL) and non‐Hodgkin lymphoma (NHL) are both malignancies
originating in the lymphatic system and both affect children, but many features differ …

Data commons have proven to be an indispensable avenue for advancing pediatric cancer
research by serving as unified information technology platforms that, when coupled with …

Abstract Children's Oncology Group (COG) trial AHOD0431 reduced systemic therapy and
used response-adapted involved-field radiotherapy (IFRT) in early-stage pediatric classic …

Every year, approximately 400 00 children worldwide are diagnosed with cancer. Although
treatment results in most types of childhood neoplasms are excellent with survival more than …

Abstract Background/purpose Pediatric Hodgkin lymphoma (HL) survivors have an
increased risk of late effects following treatment. Barriers at the patient, provider, and payor …

Objectives Evaluate the influence of an MRI contrast agent application on primary and follow-
up staging in pediatric patients with newly diagnosed lymphoma using [18F] FDG PET/MRI …

Purpose We investigated the effects of central review of the interim fluorodeoxyglucose−
positron emission tomography/computed tomography (FDG-PET/CT) scan response (iPET) …